
Aster DM Healthcare Ltd. (ASTERDM) Share Price Hits Fresh 52-Week High
Updated: 6 Aug 2026 • 10:24 am
Posted by:

Aster DM Healthcare Ltd. Share Price hits a fresh 52-week high at Rs 874, marking a 3.02% rise today. Market cap stands at Rs 72,749.78 crore.
Aster DM Healthcare Ltd. Share Price reached a fresh 52-week high today, trading at Rs 874. This marks a 3.02% increase from the previous close of Rs 840.75. The company's market capitalisation now stands at Rs 72,749.78 crore. This surge in share price highlights investor interest, although the data does not specify a company-specific catalyst for this movement. The healthcare sector, known for its resilience, may be contributing to the positive sentiment around Aster DM Healthcare Ltd.
Aster DM Healthcare Ltd. Share Price Today: Price Action Analysis
| Metric | Value |
|---|---|
| Current Price | Rs 866.1 |
| Previous Close | Rs 840.75 |
| Today's Change | +Rs 25.35 (+3.02%) |
| Day Open | Rs 832.35 |
| Fresh 52-Week High | Rs 874 |
| Day Low | Rs 811.25 |
| Current Volume | 2,76,417 |
| Turnover | Rs 23.94 crore |
| Market Capitalisation | Rs 72,749.78 crore |
Aster DM Healthcare Ltd. (ASTERDM) traded at Rs 866.1. versus the previous close of Rs 840.75, a rise of 3.02%. The stock opened at Rs 832.35, reached Rs 874, touched Rs 811.25. Reported volume was 2,76,417.
Today, Aster DM Healthcare Ltd. opened at Rs 832.35 and reached a high of Rs 874, setting a fresh 52-week high. The stock's low for the day was Rs 811.25, with a turnover of Rs 23.94 crore. The current volume of 276,417 shares indicates strong participation, reflecting a significant interest in the stock. The 3.02% rise from the previous close underscores the stock's upward momentum.
Aster DM Healthcare Ltd. (ASTERDM) Fundamental Analysis
| Metric | Value |
|---|---|
| Market Capitalisation | Rs 72,749.78 crore |
| P/E Ratio | 31.4x |
| P/B Ratio | 0.46x |
| ROE | -2.89% |
| ROCE | -0.26% |
Aster DM Healthcare Ltd. was valued at a P/E ratio of 31.4x, a P/B ratio of 0.46x. These multiples provide valuation context, but they should not be labelled expensive or inexpensive without a comparable peer or sector benchmark.
Profitability and capital efficiency were represented by ROE of -2.89% and ROCE of -0.26%. ROE relates profit to shareholder equity, while ROCE measures returns generated on the capital employed in the business.
Sector and Industry Context
| Metric | Value |
|---|---|
| Sector | Healthcare |
| Benchmark Scope | same sector |
| Company P/E Ratio | 31.4x |
| Benchmark Median P/E | 21.61x |
| Benchmark Average P/E | 72.01x |
| Benchmark P/E Range | 0x to 3,428.55x |
| Company P/B Ratio | 0.46x |
| Benchmark Median P/B | 1.92x |
| Company ROE | -2.89% |
| Benchmark Median ROE | 10.75% |
| Company ROCE | -0.26% |
| Benchmark Median ROCE | 13.29% |
| Company Market Capitalisation | Rs 72,749.78 crore |
| Benchmark Median Market Cap | Rs 139.72 crore |
Aster DM Healthcare Ltd. (ASTERDM) is classified under sector: Healthcare.
Aster DM Healthcare Ltd. (ASTERDM) has a P/E ratio of 31.4x, which is above the benchmark median of 21.61x, a difference of +45.3%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.
Aster DM Healthcare Ltd. (ASTERDM) has a ROE of -2.89%, which is below the benchmark median of 10.75%, a difference of -126.88%. Aster DM Healthcare Ltd. (ASTERDM) has a ROCE of -0.26%, which is below the benchmark median of 13.29%, a difference of -101.96%.
Track stocks reaching yearly peaks through the Univest 52-week-high screener. The peer table below provides the company-level comparison.
Peer Comparison
| Company | Symbol | Market Cap (Cr) | P/E | P/B | ROE (%) | ROCE (%) |
|---|---|---|---|---|---|---|
| Dishman Carbogen Amcis Ltd. | DCAL | 2,943.6 | 31.4 | 0.46 | -2.89 | -0.26 |
| Kwality Pharmaceuticals Ltd. | KPL | 2,684.11 | 39.39 | 8.02 | 28.21 | 26.35 |
| Beta Drugs Ltd. | BETA | 2,621.81 | 63.25 | 10.01 | 18.65 | 22.17 |
| Dr Agarwals Eye Hospital Ltd. | DRAGARWQ | 2,511.89 | 32.96 | 6.79 | -2.6 | 16.92 |
| Sai Parenteral's Ltd. | SAIPARENT | 2,347.02 | 160.63 | 2.97 | 13.9 | 12.97 |
Aster DM Healthcare Ltd. (ASTERDM) has a P/E ratio of 31.4x compared with the displayed peer median of 39.39x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of -2.89% compares with a peer median of 13.9% across the companies shown in the table. ROCE stood at -0.26% versus the displayed peer median of 16.92%, providing a capital-efficiency comparison. Aster DM Healthcare Ltd. (ASTERDM) has a market capitalisation of Rs 72,749.78 crore. Among the 5 peers shown, 0 have a larger market capitalisation.
Why Investors Are Watching Aster DM Healthcare Ltd.
- Fresh 52-week high at Rs 874, indicating strong price momentum.
- Market cap of Rs 72,749.78 crore, highlighting its significant size in the sector.
- P/E ratio above sector median, suggesting potential growth expectations.
- Low P/B ratio, indicating possible undervaluation.
- Negative ROE and ROCE, raising concerns about profitability.
About Aster DM Healthcare Ltd.
Aster DM Healthcare Ltd. is a prominent player in the healthcare sector, providing a range of services across hospitals, clinics, and pharmacies. The company operates in multiple countries, offering comprehensive healthcare solutions. Its diverse portfolio includes medical services, diagnostic centers, and wellness programs, catering to a broad spectrum of healthcare needs. Aster DM's commitment to quality care and innovation positions it as a key player in the industry.
Track Aster DM Healthcare Ltd. Share Price on Univest
Use Aster DM Healthcare Ltd. (ASTERDM) live share-price page, Univest 52-week-high screener, Univest market blogs to review live stock data, yearly-high lists and related market analysis.
Investors can track Aster DM Healthcare Ltd. Share Price, technical indicators, fundamental ratios, shareholding pattern, 52-week levels, and market insights on Univest. Stay informed with real-time data and analysis to make educated investment decisions.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
Frequently Asked Questions
What is the current share price of Aster DM Healthcare Ltd.?
Ans. The current share price of Aster DM Healthcare Ltd. is Rs 866.1, marking a 3.02% increase today and reaching a fresh 52-week high of Rs 874. The stock moved 3.02% during the session.
How does Aster DM Healthcare Ltd.'s P/E ratio compare to the sector?
Ans. Aster DM Healthcare Ltd.'s P/E ratio of 31.4 is above the sector median of 21.61, indicating higher growth expectations compared to the median. The company trades at a P/E ratio of 31.4x.
What is Aster DM Healthcare Ltd.'s market capitalisation?
Ans. Aster DM Healthcare Ltd.'s market capitalisation is Rs 72,749.78 crore, making it a significant player in the healthcare sector. The company operates in the Healthcare sector. Its P/E ratio is 31.4x.
What are the concerns regarding Aster DM Healthcare Ltd.'s profitability?
Ans. Aster DM Healthcare Ltd. reports a negative ROE of -2.89% and ROCE of -0.26%, indicating challenges in generating returns on equity and capital employed. ROE stands at -2.89%. ROCE stands at -0.26%.
How does Aster DM Healthcare Ltd.'s P/B ratio compare to the sector?
Ans. Aster DM Healthcare Ltd.'s P/B ratio of 0.46 is significantly lower than the sector median of 1.92, suggesting potential undervaluation. The company trades at a P/E ratio of 31.4x. Its P/B ratio is 0.46x.
How does Aster DM Healthcare Ltd. compare with its peers?
Ans. Aster DM Healthcare Ltd. has a higher market cap but lower profitability metrics compared to peers like Kwality Pharmaceuticals Ltd. Comparable listed companies include Dishman Carbogen Amcis Ltd., Kwality Pharmaceuticals Ltd., Beta Drugs Ltd.
What is the sector benchmark for Aster DM Healthcare Ltd.?
Ans. The sector benchmark for Aster DM Healthcare Ltd. includes a P/E median of 21.61 and a P/B median of 1.92, with 198 companies in the healthcare sector. The stock belongs to the Healthcare sector.
Recent Articles

Biogen Pharmachem Q1 Results FY27: PAT at Rs 22 Lakh for June 2026 Quarter
6 August 2026

Kkalpana Plastics Q1 Results FY27: Net Loss of Rs 8 Lakh for June 2026 Quarter
6 August 2026

Siemens India Share: Pros and Cons Every Investor Must Know in 2026
6 August 2026

Swan Defence Share Price in Focus as Company Wins Svitzer Contract for Four TRAnsverse 3200 Tugs With Deliveries From 2028
6 August 2026
Note: This blog is for information purpose only. Investments and trading are subject to market risks, read all scheme related documents carefully.
Reviews
Recent Posts
Biogen Pharmachem Q1 Results FY27: PAT at Rs 22 Lakh for June 2026 Quarter
Kkalpana Plastics Q1 Results FY27: Net Loss of Rs 8 Lakh for June 2026 Quarter
Siemens India Share: Pros and Cons Every Investor Must Know in 2026
Swan Defence Share Price in Focus as Company Wins Svitzer Contract for Four TRAnsverse 3200 Tugs With Deliveries From 2028
KJMC Financial Services Q1 Results FY27: PAT at Rs 1 Cr for June 2026 Quarter
Popular this week
Biogen Pharmachem Q1 Results FY27: PAT at Rs 22 Lakh for June 2026 Quarter
Kkalpana Plastics Q1 Results FY27: Net Loss of Rs 8 Lakh for June 2026 Quarter
Siemens India Share: Pros and Cons Every Investor Must Know in 2026
Swan Defence Share Price in Focus as Company Wins Svitzer Contract for Four TRAnsverse 3200 Tugs With Deliveries From 2028
KJMC Financial Services Q1 Results FY27: PAT at Rs 1 Cr for June 2026 Quarter

Uniresearch Global Pvt Ltd
Research Analyst
SEBI Registration Number — INH000013776
Uniresearch is a subsidiary of Univest Communication Technologies Private Limited
Company Address: Registered Address: Ground Floor, Unitech Commercial Tower 2, Block B, Greenwood City, Unit 1-3, Sector 45, Gurugram, Haryana 122003
Write to us : support@univest.in, compliance@univest.in
Verify on SEBI registry →RESEARCH ANALYST
Get SEBI Registered
advice on the stocks
trending today.
Get 3 FREE Trade Ideas
for Startups Accelerator 2024
Trusted by 1Cr Indians
Awarded No.1 by Economic Times





